Nutrition support may prolong survival in high risk patients with gastric cancer
the ONA take:
According to a new study published in the journal Supportive Care in Cancer, researchers in China have found that nutrition support might be helpful to improve the prognosis of patients with stage IV gastric cancer whose Nutritional Risk Screening (NRS) score is 3 or higher.
For the study, researchers sought to evaluate whether nutrition support can extend survival of patients with advanced gastric cancer cancer.
Researchers prospectively evaluated the nutritional risk of 830 patients with gastric adenocarcinoma. Of those, 50.7% had an NRS ≥3. Then, patients with stage IV disease whose NRS was ≥3 were given nutrition support.
Results showed that NRS ≥3 was an independent adverse prognostic factor in patients with gastric cancer. Median survival was over 6 months longer in patients with an NRS <3.
In addition, among the 347 patients with an NRS ≥3 who were given nutrition support, those who were young, male, and achieved a good response to chemotherapy were more likely to shirt to NRS <3 after nutrition support.
Researchers found that median overall survival was 14.3 months for patients with the NRS shift compared with 9.6 months for those without the shift.
Nutrition support might be helpful to improve the prognosis of patients with stage IV gastric cancer.
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Colorectal Cancer Rates Increased Sharply Among Generation X and Millennials
- Pneumonia Associated With Common Cold May Cause Fatal Illness in Stem Cell Transplant Recipients
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Antiperspirants/Deodorants and Breast Cancer (Fact Sheet)
- Genome Sequencing Explains Resistance to CTLA-4 and PD-1 Inhibitors in Metastatic Melanoma
- Lifestyle Choices Have Greater Influence on Colon and Rectal Cancer Risk
- Kidney Cancer Metastases in Lung May Hide Undiagnosed Primary Lung Cancer
- Nasal Biomarker in Smokers Could Predict Lung Cancer
- Arm Lymphoscintigraphy After Axillary Lymph Node Dissection or Sentinel Lymph Node Biopsy in Breast Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|